An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
MethylScan is a low-cost blood test that detects multiple cancers and liver diseases by analyzing DNA methylation patterns ...
A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The ...
A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...
An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...
More than 174,000 Participants Enrolled Across Both Studies, Demonstrating the Scientific Rigor of Galleri® Clinical Development Program ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
Final random-forest-based models outperformed all publicly available risk scores on internal and external test sets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results